193 related articles for article (PubMed ID: 37872422)
21. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
[TBL] [Abstract][Full Text] [Related]
22. Nationwide survey of fertility preservation in patients with hematological malignancies in Japan.
Okamoto S; Fujii N; Yoshioka N; Harada M; Tanimoto M; Maeda Y; Suzuki N; Osuga Y
Int J Clin Oncol; 2021 Feb; 26(2):438-442. PubMed ID: 33068221
[TBL] [Abstract][Full Text] [Related]
23. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
[TBL] [Abstract][Full Text] [Related]
25. ESHRE guideline: female fertility preservation.
; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
[TBL] [Abstract][Full Text] [Related]
26. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
27. Fertility preservation for cancer patients: treatment gaps and considerations in patients' choices.
Kappy M; Lieman HJ; Pollack S; Buyuk E
Arch Gynecol Obstet; 2021 Jun; 303(6):1617-1623. PubMed ID: 33544203
[TBL] [Abstract][Full Text] [Related]
28. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
[TBL] [Abstract][Full Text] [Related]
29. Preservation of fertility in female patients with hematologic diseases.
Antunes MB; Cardeal SP; Magalhães M; Vale-Fernandes E; Barreiro M; Sá R; Sousa M
Blood Rev; 2023 Nov; 62():101115. PubMed ID: 37562987
[TBL] [Abstract][Full Text] [Related]
30. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
31. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
32. Survey of understanding and awareness of fertility preservation in pediatric patients: Is conversation about fertility preservation unpleasant for pediatric patients?
Takae S; Iwahata Y; Sugishita Y; Iwahata H; Kanamori R; Shiraishi E; Ito K; Suzuki Y; Yamaya Y; Tanaka K; Oyama K; Keino D; Nakamura K; Odawara K; Horage Y; Meng L; Igualada A; Faizal AM; Aworet LO; Furuta S; Sakamoto M; Mori T; Kitagawa H; Suzuki N
Front Endocrinol (Lausanne); 2022; 13():1074603. PubMed ID: 36686445
[TBL] [Abstract][Full Text] [Related]
33. Fertility preservation in pediatric healthcare: a review.
Chen L; Dong Z; Chen X
Front Endocrinol (Lausanne); 2023; 14():1147898. PubMed ID: 37206440
[TBL] [Abstract][Full Text] [Related]
34. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
35. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
36. Optimizing the process of fertility preservation in pediatric female cancer patients - a multidisciplinary program.
Ben-Aharon I; Abir R; Perl G; Stein J; Gilad G; Toledano H; Elitzur S; Avrahami G; Ben-Haroush A; Oron G; Freud E; Kravarusic D; Ben-Arush M; Herzel G; Yaniv I; Stemmer SM; Fisch B; Ash S
BMC Cancer; 2016 Aug; 16():620. PubMed ID: 27506811
[TBL] [Abstract][Full Text] [Related]
37. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
Khiat S; Provansal M; Bottin P; Saias-Magnan J; Metzler-Guillemain C; Courbiere B
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():65-70. PubMed ID: 32784054
[TBL] [Abstract][Full Text] [Related]
38. Sperm cryopreservation prior to gonadotoxic treatment: experience of a single academic centre over 4 decades.
Shankara-Narayana N; Di Pierro I; Fennell C; Ly LP; Bacha F; Vrga L; Savkovic S; Turner L; Jayadev V; Conway AJ; Handelsman DJ
Hum Reprod; 2019 May; 34(5):795-803. PubMed ID: 30951144
[TBL] [Abstract][Full Text] [Related]
39. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
40. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
